The Stevanato Group
Veneto · Founded 1949
About The Stevanato Group
Stevanato Group is a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.
Company Facts
- Founded: 1949
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 5,001 – 10,000
- Estimated revenue: $1M – $10M
- Total funding: $797.6M
- Funding stage: IPO
- Last round: Post-IPO Debt (Jul 2025)
- Ticker: nyse:STVN
- Website: stevanatogroup.com
- Phone: 39 0499 31 81 11
Industries & Categories
Health Care, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/the-stevanato-group-99566 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.